passages.id: 697
passages.type: sentence
passages.text: Eligible patients were randomly assigned at enrollment to receive three weekly doses of epoetin alfa 40,000 U subcutaneously ( SC ) , followed by either standard weekly epoetin alfa ( 40K arm ) or 120,000 U of epoetin alfa ( 120K arm ) SC every 3 weeks for 18 additional weeks .
entities.id: 698
entities.type: intervention
entities.text: epoetin alfa
entities.id: 699
entities.type: intervention
entities.text: epoetin alfa
entities.id: 700
entities.type: intervention
entities.text: epoetin alfa